For clinicians who work in acute care settings, some practical guidance pertaining to drug–drug interactions (DDIs) for the treatment of patients with COVID-19 is finally available.

Loren Bonner

APhA Member News

Crossword Challenge

Updates from FDA

Androgenetic alopecia (AGA), also known as male pattern baldness or female pattern hair loss, affects up to 80% of men and 50% of women over their lifetime, with white men and women more likely to experience hair loss than other ethnicities.

Mary Warner

Collagen is a leader in the supplements market, advertised as a boon to joint and bone health, and a remedy for aspects of aging such as dehydration, loss of skin elasticity, and wrinkles.

Mickie Cathers

Semaglutide, a GLP-1 receptor agonist, has lowered the risk of CV events for untold patients with T2D. But does the drug offer the same protective effects to the growing number of people without diabetes who now take the drug for weight loss? New research says “yes.”

Sonya Collin

Over half of survey participants were open to using pharmacies for testing and treatment of influenza and group A streptococcal pharyngitis infections, according to study results published in the January/February 2023 issue of JAPhA. They were also willing to pay $25 or more for out-of-pocket testing costs.

Clarissa Chan, PharmD

More than 42% of Americans have obesity. Given that obesity raises risk for numerous chronic illnesses and cancers, this subset of the population likely receives a substantial proportion of the medications prescribed in the United States. But they might not be getting the right dose.

Sonya Collins

FDA warns patients not to use smartwatches or smart rings to measure blood glucose levels. Survey looks at characteristics of young adults who use e-cigarettes. CDC: Older adults should get another COVID-19 dose this spring. BP improves with patients taking GLP-1, says study. Low-dose aspirin during pregnancy appears to have no effect on child’s neurodevelopment. Age-related risk of serious falls increases with opioid use. Pennsylvania pharmacists can now bill Medicaid for pharmacy services.